Expo Living
Dubai's most affordable Emaar address - built on the Expo 2020 legacy site with Al Maktoum Airport next door.
Why Expo Living
Expo Living is built on the District 2020 master plan - the rebranded legacy of the Expo 2020 site. The infrastructure already exists: the Expo pavilions, metro connectivity, open spaces, and the beginnings of a real community. Emaar is the residential developer layering residential product onto what was already built.
The price point is the story. At AED 900–1,200 PSF, you're buying an Emaar community product with existing infrastructure and a 5-minute drive to Al Maktoum International Airport at the cheapest per-square-foot rate in the Emaar portfolio.
The long-term thesis is simple: Al Maktoum Airport when fully operational will become the world's largest airport by capacity. The land within 5 minutes of that airport will not stay at AED 900 PSF indefinitely.
Phases & Launches
Sidr Residences
Mangrove Residences
Calia Residences
Why Buy
- +Cheapest Emaar community PSF - AED 900–1,200 versus AED 1,800+ elsewhere
- +Existing Expo infrastructure (metro, roads, open spaces) already in place
- +5 minutes from Al Maktoum International - a permanent long-term catalyst
- +Studio and 1BR price points accessible for first-time buyers and smaller investors
- +Sustainability-themed community with real greenery from the Expo build
Watch Out For
- −Currently under-activated - limited retail and dining options
- −35–40 minutes to Downtown in peak traffic
- −Al Maktoum full operational timeline is uncertain (repeatedly delayed)
- −Rental market is thin until population density increases
- −Perceived as 'far from everything' by many buyers - limits secondary buyer pool today
Our Take
Expo Living is a pure infrastructure bet at the cheapest available Emaar entry point. The thesis is Al Maktoum Airport - if you believe the airport expansion will happen (it will, just on Dubai's timeline), buying within 5 minutes at AED 900 PSF today will look obvious in retrospect.
Not a yield play right now. A capital appreciation position for patient capital.